MitraClip® After Surgical Mitral Valve Repair (MVRepair)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02853955
Recruitment Status : Unknown
Verified July 2016 by Daniel Braun, MD, Klinikum der Universitaet Muenchen. Recruitment status was: Recruiting
First Posted : August 3, 2016
Last Update Posted : September 1, 2016
Klinikum der Universitaet Muenchen
Information provided by (Responsible Party):
Daniel Braun, MD, Klinikum der Universitaet Muenchen
Percutaneous edge-to-edge repair of the mitral valve has been shown to be a safe and effective alternative treatment option for selected patients at high risk for cardiac surgery. Patients with recurrent mitral regurgitation after surgical mitral valve repair (sMVR) are per se at increased risk for another cardiac surgery. The purpose of this multicenter retrospective analysis of patients treated with a MitraClip® after sMVR, is to evaluate the effectiveness and durability of this minimally invasive treatment option in this subset of patients.
Condition or disease
Device: Percutaneous edge-to-edge repair of the mitral valve
In this multicenter retrospective analysis of MitraClip® cases after MVR the effectiveness and durability of this minimally invasive treatment option in this subset of patients will be evaluated.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years to 95 Years (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
patients treated with a MitraClip® after sMVR
All patients with recurrent mitral regurgitation treated with a MitraClip®.